Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Prior to vaccine, most oropharyngeal cancers HPV+

Prior to vaccine, most oropharyngeal cancers HPV+

Most oropharyngeal cancers diagnosed in the U.S. between 1995 and 2005 tested positive for HPV.

Codeine still prescribed for kids' cough

Codeine still prescribed for kids' cough

Despite national recommendations against prescribing codeine for children, research suggests little decline in prescription rates.

Nebraska governor vetoed bill for NP autonomy

Nebraska governor vetoed bill for NP autonomy

LB 916 would have eliminated the legal requirement that NPs sign a practice agreement with a doctor.